Relationship between smoking and metabolic syndrome

Nutrition Reviews

Volumn 69, Issue 12, 2011, Pages 745-753

  Cena, Hellas ^a   Fonte, Maria Luisa ^a   Turconi, Giovanna ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

Body composition; Health; Inflammation; Obesity; Smoking

Indexed keywords

ESTROGEN; GHRELIN; INSULIN; LEPTIN; NEUROPEPTIDE Y; NICOTINE; TESTOSTERONE;

APPETITE; BODY MASS; BODY WEIGHT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC DISEASE; CIGARETTE SMOKING; DIETARY INTAKE; DISEASE ASSOCIATION; DNA METHYLATION; ENERGY EXPENDITURE; FEMALE; GLYCEMIC CONTROL; HEALTH SURVEY; HORMONE ACTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOGENESIS; PREVALENCE; REVIEW; RISK; RISK REDUCTION; SEX DIFFERENCE; SMOKING CESSATION; TOBACCO; WAIST CIRCUMFERENCE; WEIGHT GAIN;

BODY MASS INDEX; CHRONIC DISEASE; COMORBIDITY; HUMANS; LIFE EXPECTANCY; METABOLIC SYNDROME X; MORBIDITY; OBESITY; RISK FACTORS; SMOKING; SMOKING CESSATION;

EID: 82955193077     PISSN: 00296643     EISSN: 17534887     Source Type: Journal    
DOI: 10.1111/j.1753-4887.2011.00446.x     Document Type: Review

References (123)

1. Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Actual causes of death in the United States, 2000. JAMA. 2004;291:1238-1245.
2. Haslam DW, James WP. Obesity. Lancet. 2005;366:1197-1209.
3. World Health Organization. Tobacco Free Initiative: Why Is Tobacco a Public Health Priority. 2011. Available at:. Accessed 31 January 2011.
4. Peeters A, Barendregt JJ, Willekens F, etal. Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Ann Intern Med. 2003;138:24-32.
5. Freedman DM, Sigurdson AJ, Rajaraman P, etal. The mortality risk of smoking and obesity combined. Am J Prev Med. 2006;1:355-362.
6. Ezzati M, Lopez AD. Regional, disease specific patterns of smoking attributable mortality in 2000. Tob Control. 2004;13:388-395.
7. Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2005;28:2289-2304.
8. Eckel RH, Alberti KG, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2010;375:181-183.
9. Sattar N. Why metabolic syndrome criteria have not made prime time: a view from the clinic. Int J Obes. 2008;32(Suppl):S30-S34.
10. Wannamethee SG, Shaper AG, Lennon L, Morris RW. Metabolic syndrome vs Framingham risk score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Intern Med. 2005;165:2644-2650.
11. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus: provisional report of WHO consultation. Diabetes Med. 1998;15:539-553.
12. National Cholesterol Education Program (NCEP). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): final report. Circulation. 2002;106:3143-3421.
13. Einhorn D, Reaven D, Reaven GM, etal. American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract. 2003;9:240-252.
14. Balkau B, Charles MA, for the European Group for the Study of Insulin Resistance. Comment to the provisional report from the WHO consultation. Diabetic Med. 1999;16:442-443.
15. Alberti G, Zimmet PZ, Shaw J, Grundy SM. International Diabetes Federation 2006: The IDF Consensus Worldwide Definition of the Metabolic Syndrome. 2006. Available at:. Accessed 11 February 2011.
16. Koskinen J, Kahonen M, Viikari JS, etal. Conventional cardiovascular risk factors and metabolic syndrome in predicting carotid intima media thickness progression in young adults: the Cardiovascular Risk in Young Finns study. Circulation. 2009;120:229-236.
17. Istituto Superiore di Sanità. Progetto Cuore. 2009. Accessed 31 October 2011.
18. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002;287:356-359.
19. Vanhala MJ, Kumpusalo EA, Pitkäjärvi TK, Takala JK. Metabolic syndrome in a middle-aged Finnish population. J Cardiovasc Risk. 1997;4:291-295.
20. Weitzman M, Cook S, Auinger P, etal. Tobacco smoke exposure is associated with the metabolic syndrome in adolescents. Circulation. 2005;112:862-869.
21. Frati AC, Iniestra F, Ariza CR. Acute effect of cigarette smoking on glucose tolerance and other cardiovascular risk factors. Diabetes Care. 1996;19:112-118.
22. Facchini FS, Hollenbeck CB, Jeppesen J, Chen YD, Reaven GM. Insulin resistance and cigarette smoking. Lancet. 1992;339:1128-1130.
23. Rönnemaa T, Rönnemaa EM, Puukka P, Pyörälä K, Laakso M. Smoking is independently associated with high plasma insulin levels in non diabetic men. Diabetes Care. 1996;19:1229-1232.
24. Targher G, Alberiche M, Zenere MB, Bonadonna RC, Muggeo M, Bonora E. Cigarette smoking and insulin resistance in patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1997;82:3619-3624.
25. Attvall S, Fowelin J, Lager I, Von Schenck H, Smith U. Smoking induces insulin resistance: a potential link with the insulin resistance syndrome. J Intern Med. 1993;233:327-332.
26. Wada T, Urashima M, Fukumoto T. Risk of metabolic syndrome persists twenty years after the cessation of smoking. Intern Med. 2007;46:1079-1082.
27. Razay G, Heaton KW. Smoking habits and lipoproteins in British women. Quart J Med. 1995;88:503-508.
28. Lee WY, Jung CH, Park JS, Rhee EJ, Kim SW. Effects of smoking, alcohol, exercise, education, and family history on the metabolic syndrome as defined by the ATP III. Diabetes Res Clin Pract. 2005;67:70-77.
29. Tsiara S, Elisaf M, Mikhailidis DP. Influence of smoking on predictors of vascular disease. Angiology. 2003;54:507-530.
30. Steiner G, Schwartz L, Shumak S, Poapst M. The association of increased levels of intermediate-density lipoproteins with smoking and with coronary artery disease. Circulation. 1987;75:124-130.
31. Criqui MH, Wallace RB, Heiss G, Mishkel M, Schonfeld G, Jones GT. Cigarette smoking and plasma high-density lipoprotein cholesterol. The Lipid Research Clinics Program Prevalence Study. Circulation. 1980;62:IV70-IV76.
32. Nakanishi N, Takatorige T, Suzuki K. Cigarette smoking and the risk of the metabolic syndrome in middle-aged Japanese male office workers. Ind Health. 2005;43:295-301.
33. Miyatake N, Wada J, Kawasaki Y, Nishii K, Makino H, Numata T. Relationship between metabolic syndrome and cigarette smoking in the Japanese population. Intern Med. 2006;45:1039-1043.
34. Geslain-Biquez C, Vol S, Tichet J, Caradec A, D'Hour A, Balkau B. The metabolic syndrome in smokers. The D.E.S.I.R. study. Diabetes Metab. 2003;29:226-234.
35. Saarni SE, Pietilainen K, Kantonen S, Rissanen A, Kaprio J. Association of smoking in adolescence with abdominal obesity in adulthood: a follow-up study of 5 birth cohorts of Finnish twins. Am J Public Health. 2009;99:348-354.
36. Kawada T, Otsuka T, Inagaki H, etal. Association of smoking status, insulin resistance, body mass index, and metabolic syndrome in workers: a 1-year follow-up study. Obes Res Clin Pract. 2010;4:e163-e169.
37. Reaven G, Tsao PS. Insulin resistance and compensatory hyperinsulinemia: the key player between cigarette smoking and cardiovascular disease? J Am Coll Cardiol. 2003;41:1044-1047.
38. Beaser RS, Levy P. Metabolic syndrome: a work in progress, but a useful construct. Circulation. 2007;115:1812-1818.
39. Gallou-Kabani C, Junien C. Nutritional epigenomics of metabolic syndrome: new perspective against the epidemic. Diabetes. 2005;54:1899-1906.
40. Maier S, Olek A. Diabetes: a candidate disease for efficient DNA methylation profiling. J Nutr. 2002;132(Suppl 8):S2440-S2443.
41. Wren JD, Garner HR. Data-mining analysis suggests an epigenetic pathogenesis for type 2 diabetes. J Biomed Biotechnol. 2005;2005:104-112.
42. Belinsky SA, Palmisano WA, Gilliland FD, etal. Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers. Cancer Res. 2002;62:2370-2377.
43. Ross CM. Letter regarding article by Weitzman etal. "Tobacco smoke exposure is associated with the metabolic syndrome in adolescents. Circulation. 2006;113:e393. Author reply e393.
44. Eliasson B, Attvall S, Taskinen MR, Smith U. The insulin resistance syndrome in smokers is related to smoking habits. Arterioscler Thromb. 1994;14:1946-1950.
45. Ronnemaa T, Ronnemaa EM, Puukka P, Pyorala K, Laakso M. Smoking is independently associated with high plasma insulin levels in nondiabetic men. Diabetes Care. 1996;19:1229-1232.
46. Eliasson B, Taskinen MR, Smith U. Long-term use of nicotine gum is associated with hyperinsulinemia and insulin resistance. Circulation. 1996;94:878-881.
47. Eliasson B, Attvall S, Taskinen MR, Smith U. Smoking cessation improves insulin sensitivity in healthy middle-aged men. Eur J Clin Invest. 1997;27:450-456.
48. Eliasson B. Cigarette smoking and diabetes. Prog Cardiovasc Dis. 2003;45:405-413.
49. Willi C, Bodenmann P, Ghali WA, Faris PD, Cornuz J. Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. 2007;298:2654-2664.
50. Manson JE, Ajani UA, Liu S, Nathan DM, Hennekens CH. A prospective study of cigarette smoking and the incidence of diabetes mellitus among U.S. male physicians. Am J Med. 2000;109:538-542.
51. Rimm EB, Manson JE, Stampfer MJ, etal. Cigarette smoking and the risk of diabetes in women. Am J Public Health. 1993;83:211-214.
52. Hu FB, Manson JE, Stampfer MJ, etal. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med. 2001;345:790-797.
53. Will JC, Galuska DA, Ford ES, Mokdad A, Calle EE. Cigarette smoking and diabetes mellitus: evidence of a positive association from a large prospective cohort study. Int J Epidemiol. 2001;30:540-546.
54. Rimm EB, Chan J, Stampfer MJ, Colditz GA, Willett WC. Prospective study of cigarette smoking, alcohol use, and the risk of diabetes in men. BMJ. 1995;310:555-559.
55. Targher G, Alberiche M, Zenere MB, Bonadonna RC, Muggeo M, Bonora E. Cigarette smoking and insulin resistance in patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1997;82:3619-3624.
56. Koska J, Stefan N, Permana PA, etal. Increased fat accumulation in liver may link insulin resistance with subcutaneous abdominal adipocyte enlargement, visceral adiposity, and hypoadiponectinemia in obese individuals. Am J Clin Nutr. 2008;87:295-302.
57. Maury E, Brichard SM. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol. 2010;314:1-16.
58. Friedman J. Fat in all the wrong places. Nature. 2002;415:268-269.
59. Mizuno O, Okamoto K, Sawada M, Mimura M, Watanabe T, Morishita T. Obesity and smoking: relationship with waist circumference and obesity-related disorders in men undergoing a health screening. J Atheroscler Thromb. 2005;12:199-204.
60. Han TS, Sattar N, Lean M. ABC of obesity. Assessment of obesity and its clinical implications. BMJ. 2006;333:695-698.
61. Pasquali R, Vicennati V. Activity of the hypothalamic-pituitary-adrenal axis in different obesity phenotypes. Int J Obes Relat Metab Disord. 2000;24(Suppl):S47-S49.
62. Cryer PE, Haymond MW, Santiago JV, Shah SD. Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. N Engl J Med. 1976;295:573-577.
63. Friedman AJ, Ravnikar VA, Barbieri RL. Serum steroid hormone profiles in postmenopausal smokers and nonsmokers. Fertil Steril. 1987;47:398-401.
64. Williamson DF, Madans J, Anda RF, Kleinman JC, Giovino GA, Byers T. Smoking cessation and severity of weight gain in a national cohort. N Engl J Med. 1991;324:739-745.
65. Yoshida T, Sakane N, Umekawa T, etal. Nicotine induces uncoupling protein 1 in white adipose tissue of obese mice. Int J Obes Relat Metab Disord. 1999;23:570-575.
66. Haarbo J, Marslew U, Gotfredsen A, Christiansen C. Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause. Metabolism. 1991;40:1323-1326.
67. Bjorntorp P. Abdominal obesity and the development of noninsulin-dependent diabetes mellitus. Diabetes Metab Rev. 1988;4:615-622.
68. Evans DJ, Barth JH, Burke CW. Body fat topography in women with androgen excess. Int J Obes. 1988;12:157-162.
69. Elbers JM, Asscheman H, Seidell JC, Megens JA, Gooren LJ. Long-term testosterone administration increases visceral fat in female to male transsexuals. J Clin Endocrinol Metab. 1997;82:2044-2047.
70. Khaw KT, Tazuke S, Barrett-Connor E. Cigarette smoking and levels of adrenal androgens in postmenopausal women. N Engl J Med. 1988;318:1705-1709.
71. Michnovicz JJ, Hershcopf RJ, Naganuma H, Bradlow HL, Fishman J. Increased 2-hydroxylation of estradiol as a possible mechanism for the anti-estrogenic effect of cigarette smoking. N Engl J Med. 1986;315:1305-1309.
72. Dai WS, Gutai JP, Kuller LH, Cauley JA. Cigarette smoking and serum sex hormones in men. Am J Epidemiol. 1988;128:796-805.
73. Barrett-Connor E, Khaw KT. Cigarette smoking and increased endogenous estrogen levels in men. Am J Epidemiol. 1987;126:187-192.
74. Vermeulen A, Goemaere S, Kaufman JM. Testosterone, body composition and aging. J Endocrinol Invest. 1999;22:110-116.
75. Marin P. Testosterone and regional fat distribution. Obes Res. 1995;3(Suppl):S609-S612.
76. Meikle AW, Liu XH, Taylor GN, Stringham JD. Nicotine and cotinine effects on 3 alpha hydroxysteroid dehydrogenase in canine prostate. Life Sci. 1988;43:1845-1850.
77. Eliasson B, Smith U. Leptin levels in smokers and long-term users of nicotine gum. Eur J Clin Invest. 1999;29:145-152.
78. Kennedy A, Gettys TW, Watson P, etal. The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure. J Clin Endocrinol Metab. 1997;82:1293-1300.
79. Saad MF, Damani S, Gingerich RL, etal. Sexual dimorphism in plasma leptin concentration. J Clin Endocrinol Metab. 1997;82:579-584.
80. Considine RV, Sinha MK, Heiman ML, etal. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med. 1996;334:292-295.
81. Taylor SI, Barr V, Reitman M. Does leptin contribute to diabetes caused by obesity? Science. 1996;274:1151-1152.
82. Nicklas BJ, Tomoyasu N, Muir J, Goldberg AP. Effects of cigarette smoking and its cessation on body weight and plasma leptin levels. Metabolism. 1999;48:804-808.
83. Perkins KA, Fonte C. Effects of smoking status and smoking cessation on leptin levels. Nicotine Tob Res. 2002;4:459-466.
84. Martin LJ, Kissebah AH, Sonnenberg GE, Blangero J, Comuzzie AG. Metabolic Risk Complications of Obesity Genes Project. Genotype-by-smoking interaction for leptin levels in the Metabolic Risk Complications of Obesity Genes project. Int J Obes Relat Metab Disord. 2003;27:334-340.
85. Filozof C, Fernandez Pinilla MC, Fernandez-Cruz A. Smoking cessation and weight gain. Obes Rev. 2004;5:95-103.
86. Hodge AM, Westerman RA, de Courten MP, Collier GR, Zimmet PZ, Alberti KG. Is leptin sensitivity the link between smoking cessation and weight gain? Int J Obes Relat Metab Disord. 1997;21:50-53.
87. Wei M, Stern MP, Haffner SM. Serum leptin levels in Mexican Americans and non-Hispanic whites: association with body mass index and cigarette smoking. Ann Epidemiol. 1997;7:81-86.
88. Larsson H, Ahren B. Smoking habits and circulating leptin in postmenopausal non-obese women. Diabetes Obes Metab. 1999;1:57-59.
89. Donahue RP, Zimmet P, Bean JA, etal. Cigarette smoking, alcohol use, and physical activity in relation to serum leptin levels in a multiethnic population: the Miami Community Health Study. Ann Epidemiol. 1999;9:108-113.
90. Lee H, Joe KH, Kim W, etal. Increased leptin and decreased ghrelin level after smoking cessation. Neurosci Lett. 2006;409:47-51.
91. Chagnon YC, Wilmore JH, Borecki IB, etal. Associations between the leptin receptor gene and adiposity in middle-aged Caucasian males from the HERITAGE family study. J Clin Endocrinol Metab. 2000;85:29-34.
92. Mattevi VS, Zembrzuski VM, Hutz MH. Association analysis of genes involved in the leptin-signaling pathway with obesity in Brazil. Int J Obes Relat Metab Disord. 2002;26:1179-1185.
93. Quinton ND, Lee AJ, Ross RJ, Eastell R, Blakemore AI. A single nucleotide polymorphism (SNP) in the leptin receptor is associated with BMI, fat mass and leptin levels in postmenopausal Caucasian women. Hum Genet. 2001;108:233-236.
94. Van Rossum CT, Hoebee B, van Baak MA, Mars M, Saris WH, Seidell JC. Genetic variation in the leptin receptor gene, leptin, and weight gain in young Dutch adults. Obes Res. 2003;11:377-386.
95. Mantzoros CS. The role of leptin in human obesity and disease: a review of current evidence. Ann Intern Med. 1999;130:671-680.
96. Bishop C, Parker GC, Coscina DV. Nicotine and its withdrawal alter feeding induced by paraventricular hypothalamic injections of neuropeptide Y in Sprague-Dawley rats. Psychopharmacology. 2002;162:265-272.
97. Li MD, Parker SL, Kane JK. Regulation of feeding-associated peptides and receptors by nicotine. Mol Neurobiol. 2000;22:143-165.
98. Chen H, Hansen MJ, Jones JE, etal. Regulation of hypothalamic NPY by diet and smoking. Peptides. 2007;28:384-389.
99. Chen H, Vlahos R, Bozinovski S, Jones J, Anderson GP, Morris MJ. Effect of short-term cigarette smoke exposure on body weight, appetite and brain neuropeptide Y in mice. Neuropsychopharmacology. 2005;30:713-719.
100. Jo YH, Talmage DA, Role LW. Nicotinic receptor-mediated effects on appetite and food intake. J Neurobiol. 2002;53:618-632.
101. Bouros D, Tzouvelekis A, Anevlavis S, etal. Smoking acutely increases plasma ghrelin concentrations. Clin Chem. 2006;52:777-778.
102. Klesges RC, Winders SE, Meyers AW, etal. How much weight gain occurs following smoking cessation? A comparison of weight gain using both continuous and point prevalence abstinence. J Consult Clin Psychol. 1997;65:286-291.
103. Flegal KM, Troiano RP, Pamuk ER, Kuczmarski RJ, Campbell SM. The influence of smoking cessation on the prevalence of overweight in the United States. N Engl J Med. 1995;333:1165-1170.
104. Parsons AC, Shraim M, Inglis J, Aveyard P, Hajek P. Interventions for preventing weight gain after smoking cessation. Cochrane Database Syst Rev. 2009;(1):CD006219.
105. LaRowe TL, Piper ME, Schlam TR, Fiore MC, Baker TB. Obesity and smoking: comparing cessation treatment seekers with the general smoking population. Obesity. 2009;17:1301-1305.
106. Albanes D, Jones DY, Micozzi MS, Mattson ME. Associations between smoking and body weight in the U.S. population: analysis of NHANES II. Am J Public Health. 1987;77:439-444.
107. Ward KD, Klesges RC, Vander Weg MW. Cessation of smoking and body weight. In: Björntop P, ed. International Textbook of Obesity. Chichester, UK: Wiley & Sons Ltd; 2001:323-336.
108. Kruger J, Ham SA, Prohaska TR. Behavioral risk factors associated with overweight and obesity among older adults: the 2005 National Health Interview Survey. Prev Chronic Dis. 2009;6:A14.
109. Kim BJ, Kim BS, Sung KC, Kang JH, Lee MH, Park JR. Association of smoking status, weight change, and incident metabolic syndrome in men: a 3-year follow-up study. Diabetes Care. 2009;32:1314-1316.
110. Bradley DP, Johnson LA, Zhang Z, etal. Effect of smoking status on total energy expenditure. Nutr Metab. 2010;7(81):1-6.
111. Chiolero A, Faeh D, Paccaud F, Cornuz J. Consequences of smoking for body weight, body fat distribution, and insulin resistance. Am J Clin Nutr. 2008;87:801-809.
112. Dallosso HM, James WP. The role of smoking in the regulation of energy balance. Int J Obes. 1984;8:365-375.
113. Hofstetter A, Schutz Y, Jequier E, Wahren J. Increased 24-hour energy expenditure in cigarette smokers. N Engl J Med. 1986;314:79-82.
114. Walker J, Collins LC, Nannini L, Stamford BA. Potentiating effects of cigarette smoking and moderate exercise on the thermic effect of a meal. Int J Obes Relat Metab Disord. 1992;16:341-347.
115. Stamford BA, Matter S, Fell RD, Papanek P. Effects of smoking cessation on weight gain, metabolic rate, caloric consumption, and blood lipids. Am J Clin Nutr. 1986;43:486-494.
116. Burse RL, Bynum GD, Pandolf KB, Goldman RF, Sims EAH, Danforth E. Increased appetite and unchanged metabolism upon cessation of smoking with diet held constant. Physiologist. 1975;18:157.
117. Moffatt RJ, Owens SG. Cessation from cigarette smoking: changes in body weight, body composition, resting metabolism, and energy consumption. Metabolism. 1991;40:465-470.
118. Koster A, Leitzmann MF, Schatzkin A, etal. The combined relations of adiposity and smoking on mortality. Am J Clin Nutr. 2008;88:1206-1212.
119. Taylor DH Jr, Hasselblad V, Henley SJ, Thun MJ, Sloan FA. Benefits of smoking cessation for longevity. Am J Public Health. 2002;92:990-996.
120. Pisinger C, Jorgensen T. Waist circumference and weight following smoking cessation in a general population: the Inter99 study. Prev Med. 2007;44:290-295.
121. Chiang PH, Chang TY, Chen JD. Synergistic effect of fatty liver and smoking on metabolic syndrome. World J Gastroenterol. 2009;15:5334-5339.
122. World Health Organization. World Health Report 2002: Reducing Risks, Promoting Healthy Life. Geneva, Switzerland: WHO; 2002. Available at:. Accessed 31 October 2011.
123. World Health Organization. In: Branca F, Nikogosian H, Lobstein T, eds. The Challenge of Obesity in the WHO European Region and the Strategies for Response. Copenhagen, Denmark: WHO; 2007. Available at:. Accessed 31 October 2011.